Acciones del sector sanitario
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1003 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.01 USD | -3.69% | -1.36% | +12.27% | +41.09% | 8.42 B USD | ||
| 1009 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 129.89 USD | -1.16% | -2.04% | +18.08% | +72.89% | 8.35 B USD | ||
| 1012 |  APGE Apogee Therapeutics, Inc. - Common Stock | 133.82 USD | +0.13% | +0.25% | +49.25% | +149.71% | 8.28 B USD | ||
| 1016 |  PCVX Vaxcyte, Inc. - Common Stock | 57.03 USD | -2.03% | -1.30% | +19.53% | +34.82% | 8.23 B USD | ||
| 1024 |  RGEN Repligen Corporation - Common Stock | 144.88 USD | +0.44% | +0.21% | +8.35% | -12.56% | 8.17 B USD | ||
| 1025 |  IBRX ImmunityBio, Inc. - Common Stock | 7.79 USD | -5.23% | -13.06% | +7.45% | +166.78% | 8.16 B USD | ||
| 1026 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 93.73 USD | -4.10% | +5.46% | +14.91% | +292.01% | 8.14 B USD | ||
| 1031 |  HQY HealthEquity, Inc. - Common Stock | 95.66 USD | +1.33% | -2.16% | +7.76% | -1.00% | 8.00 B USD | ||
| 1035 |  ATR AptarGroup, Inc. Common Stock | 124.90 USD | -0.51% | -1.51% | +5.72% | -20.69% | 7.97 B USD | ||
| 1036 |  BIO Bio-Rad Laboratories, Inc. Class A Common Stock | 297.56 USD | +0.48% | -0.36% | +2.96% | -11.62% | 7.96 B USD | ||
| 1041 |  IMVT Immunovant, Inc. - Common Stock | 38.70 USD | -2.54% | -0.77% | +14.50% | +101.46% | 7.95 B USD | ||
| 1065 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 60.94 USD | -3.94% | -3.73% | +17.76% | +53.69% | 7.62 B USD | ||
| 1081 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.49 USD | -0.84% | -4.88% | +15.58% | -2.56% | 7.37 B USD | ||
| 1088 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 119.04 USD | -2.53% | -3.69% | +19.65% | +69.74% | 7.26 B USD | ||
| 1120 |  LNTH Lantheus Holdings, Inc. - Common Stock | 105.39 USD | -0.24% | +3.83% | +0.59% | +88.00% | 6.86 B USD | ||
| 1122 |  PACS PACS Group, Inc. Common Stock | 43.29 USD | +0.12% | -4.12% | +16.59% | +236.89% | 6.85 B USD | ||
| 1156 |  SRRK Scholar Rock Holding Corporation - Common Stock | 54.70 USD | -3.54% | -1.48% | +22.07% | +82.21% | 6.55 B USD | ||
| 1159 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 67.72 USD | -1.74% | +10.83% | +29.88% | +66.02% | 6.55 B USD | ||
| 1161 |  CHE Chemed Corp | 492.28 USD | +0.80% | +1.43% | +17.61% | +6.45% | 6.53 B USD | ||
| 1176 |  COGT Cogent Biosciences, Inc. - Common Stock | 37.46 USD | -3.63% | -6.12% | +12.16% | +139.06% | 6.40 B USD |
Noticias Acciones del sector sanitario
Mesoblast alcanza 300 pacientes en ensayo para el dolor de espalda
Alex Thurman, CFO de Glaukos, vende 1,55 millones de dólares en acciones
El presidente de Arcus Biosciences, Juan C. Jaen, vende 2,03 millones de dólares en acciones
S&P Global mejora perspectiva de Revvity por reducción de apalancamiento
El director de operaciones técnicas de PTC Therapeutics vende acciones por 222.376 dólares
Mary L. Smith, directora de PTC Therapeutics, vende 1,43 millones de dólares en acciones
El CFO de Dianthus Therapeutics vende acciones por 3,16 millones de dólares
Gainers Acciones del sector sanitario
 XAIR Beyond Air, Inc. - Common Stock | 7.49 | +1683.33% |
 QTTB Q32 Bio Inc. - Common Stock | 21.38 | +90.72% |
 AGEN Agenus Inc. - Common Stock | 6.12 | +82.69% |
 SRXH SRX Health Solutions, Inc. Common Stock | 2.78 | +31.13% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.50 | +23.97% |
 TOIIW The Oncology Institute, Inc. - Warrant | 0.0597 | +19.64% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0239 | +19.50% |
 GALT Galectin Therapeutics Inc. - Common Stock | 4.60 | +13.30% |
Losers Acciones del sector sanitario
 MTNB Matinas Biopharma Holdings, Inc. Common Stock | 0.49 | -33.78% |
 AEON AEON Biopharma, Inc. Class A Common Stock | 0.32 | -33.33% |
 LUCYW Innovative Eyewear, Inc. - Warrants | 0.0537 | -29.34% |
 BIVI BioVie Inc. - Common stock | 1.64 | -27.75% |
 ZCMD Zhongchao Inc. - Class A Ordinary Shares | 1.51 | -25.62% |
 APLM Apollomics Inc. - Class A Ordinary Shares | 14.21 | -25.01% |
 HUMAW Humacyte, Inc. - Warrant | 0.0076 | -24.00% |
 AARD Aardvark Therapeutics, Inc. - Common Stock | 5.96 | -21.58% |